WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 562493

CAS#: 16837-52-8

Description: Oxymatrine is a protective agent against apoptosis, tumor and fibrotic tissue development, and inflammation.

Chemical Structure

CAS# 16837-52-8

Theoretical Analysis

MedKoo Cat#: 562493
Name: Oxymatrine
CAS#: 16837-52-8
Chemical Formula: C15H24N2O2
Exact Mass: 264.1838
Molecular Weight: 264.36
Elemental Analysis: C, 68.15; H, 9.15; N, 10.60; O, 12.10

Price and Availability

Size Price Availability Quantity
100.0mg USD 220.0 2 Weeks
500.0mg USD 390.0 2 Weeks
1.0g USD 650.0 2 Weeks
Bulk inquiry

Synonym: Matrine N-oxide; Ammothamnine; Oxysophoridine; Matrine oxide; Matrine 1beta-oxide; Oxymatrine;

IUPAC/Chemical Name: (4R,41R,7aS,13aR,13bR)-10-oxododecahydro-1H,5H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridine 4(41H)-oxide


InChi Code: InChI=1S/C15H24N2O2/c18-14-7-1-6-13-12-5-3-9-17(19)8-2-4-11(15(12)17)10-16(13)14/h11-13,15H,1-10H2/t11-,12+,13+,15+,17+/m0/s1

SMILES Code: O=C1CCC[C@@H]2[C@H]3CCC[N@@+]4([O-])[C@@H]3[C@@H](CCC4)CN21

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 264.36 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Shen CY, Jiang JG, Yang L, Wang DW, Zhu W. Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery. Br J Pharmacol. 2017 Jun;174(11):1395-1425. doi: 10.1111/bph.13631. Epub 2016 Oct 29. Review. PubMed PMID: 27659301; PubMed Central PMCID: PMC5429334.

2: He M, Wu Y, Wang M, Chen W, Jiang J. Meta-analysis of the clinical value of oxymatrine on sustained virological response in chronic hepatitis B. Ann Hepatol. 2016 Jul-Aug;15(4):482-91. Review. PubMed PMID: 27236147.

3: Lu ML, Xiang XH, Xia SH. Potential Signaling Pathways Involved in the Clinical Application of Oxymatrine. Phytother Res. 2016 Jul;30(7):1104-12. doi: 10.1002/ptr.5632. Epub 2016 May 10. Review. PubMed PMID: 27165263.

4: Parvez MK, Arbab AH, Al-Dosari MS, Al-Rehaily AJ. Antiviral Natural Products Against Chronic Hepatitis B: Recent Developments. Curr Pharm Des. 2016;22(3):286-93. Review. PubMed PMID: 26561057.

5: He M, Wu Y, Wang M, Chen W, Yuan W, Jiang J. The Clinical Value of Oxymatrine in Preventing Lamivudine Induced YMDD Mutation: A Meta-Analysis. Evid Based Complement Alternat Med. 2015;2015:971616. doi: 10.1155/2015/971616. Epub 2015 Oct 5. Review. PubMed PMID: 26508988; PubMed Central PMCID: PMC4609836.

6: Song WJ, Luo J, Wu T, Yao SK. Oral oxymatrine preparation for chronic hepatitis B: A systematic review of randomized controlled trials. Chin J Integr Med. 2016 Feb;22(2):141-9. doi: 10.1007/s11655-015-2143-0. Epub 2015 May 26. Review. PubMed PMID: 26016455.

7: Wang W, You RL, Qin WJ, Hai LN, Fang MJ, Huang GH, Kang RX, Li MH, Qiao YF, Li JW, Li AP. Anti-tumor activities of active ingredients in Compound Kushen Injection. Acta Pharmacol Sin. 2015 Jun;36(6):676-9. doi: 10.1038/aps.2015.24. Epub 2015 May 18. Review. PubMed PMID: 25982630; PubMed Central PMCID: PMC4594177.

8: Unahabhokha T, Sucontphunt A, Nimmannit U, Chanvorachote P, Yongsanguanchai N, Pongrakhananon V. Molecular signalings in keloid disease and current therapeutic approaches from natural based compounds. Pharm Biol. 2015 Mar;53(3):457-63. doi: 10.3109/13880209.2014.918157. Epub 2014 Oct 21. Review. PubMed PMID: 25331681.

9: Wang CY, Bai XY, Wang CH. Traditional Chinese medicine: a treasured natural resource of anticancer drug research and development. Am J Chin Med. 2014;42(3):543-59. doi: 10.1142/S0192415X14500359. Review. PubMed PMID: 24871650.

10: Liu Y, Xu Y, Ji W, Li X, Sun B, Gao Q, Su C. Anti-tumor activities of matrine and oxymatrine: literature review. Tumour Biol. 2014 Jun;35(6):5111-9. doi: 10.1007/s13277-014-1680-z. Epub 2014 Feb 14. Review. PubMed PMID: 24526416.

11: Narayana Moorthy NS, Ramos MJ, Fernandes PA. Human ether-a-go-go-related gene channel blockers and its structural analysis for drug design. Curr Drug Targets. 2013 Jan 1;14(1):102-13. Review. PubMed PMID: 23061466.

12: Hu YY. Pay attention to the study on active antiliver fibrosis components of Chinese herbal medicine. Chin J Integr Med. 2012 Aug;18(8):563-4. doi: 10.1007/s11655-012-1029-7. Epub 2012 Mar 21. Review. PubMed PMID: 22438172.

13: Cui X, Wang Y, Kokudo N, Fang D, Tang W. Traditional Chinese medicine and related active compounds against hepatitis B virus infection. Biosci Trends. 2010 Apr;4(2):39-47. Review. PubMed PMID: 20448340.

14: Ho JW, Ngan Hon PL, Chim WO. Effects of oxymatrine from Ku Shen on cancer cells. Anticancer Agents Med Chem. 2009 Oct;9(8):823-6. Review. PubMed PMID: 19538168.

15: Azzam HS, Goertz C, Fritts M, Jonas WB. Natural products and chronic hepatitis C virus. Liver Int. 2007 Feb;27(1):17-25. Review. Erratum in: Liver Int. 2007 Apr;27(3):421. PubMed PMID: 17241377.

16: Sungnoon R, Chattipakorn N. Anti-arrhythmic effects of herbal medicine. Indian Heart J. 2005 Mar-Apr;57(2):109-13. Review. PubMed PMID: 16013349.

17: Zhang MJ, Huang J. [Recent research progress of anti-tumor mechnism matrine]. Zhongguo Zhong Yao Za Zhi. 2004 Feb;29(2):115-8. Review. Chinese. PubMed PMID: 15719674.

18: Wu XN, Wang GJ. Experimental studies of oxymatrine and its mechanisms of action in hepatitis B and C viral infections. Chin J Dig Dis. 2004;5(1):12-6. Review. PubMed PMID: 15612666.

19: Coon JT, Ernst E. Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review. J Hepatol. 2004 Mar;40(3):491-500. Review. PubMed PMID: 15123365.

20: Liu J, Manheimer E, Tsutani K, Gluud C. Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials. Am J Gastroenterol. 2003 Mar;98(3):538-44. Review. PubMed PMID: 12650784.


100.0mg / USD 220.0